Clinical trial
FINE-REAL: A Non-interventional Study Providing Insights Into the Use of Finerenone in a Routine Clinical Setting
NCT05348733 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FINE-REAL: A Non-interventional Study Providing Insights Into the Use of Finerenone in a Routine Clinical Setting
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 13, 2022
- Completion date
- December 22, 2026
- Enrollment
- 4,613 (actual)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, type 2 diabetes mellitus